Search by Drug Name or NDC

    NDC 41250-0117-03 lansoprazole 15 mg/1 Details

    lansoprazole 15 mg/1

    lansoprazole is a ORAL CAPSULE, DELAYED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by Meijer Distribution Inc. The primary component is LANSOPRAZOLE.

    Product Information

    NDC 41250-0117
    Product ID 41250-117_c7df2594-5fe3-455f-896a-92797c0f14e2
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name lansoprazole
    Proprietary Name Suffix n/a
    Non-Proprietary Name Lansoprazole
    Product Type HUMAN OTC DRUG
    Dosage Form CAPSULE, DELAYED RELEASE
    Route ORAL
    Active Ingredient Strength 15
    Active Ingredient Units mg/1
    Substance Name LANSOPRAZOLE
    Labeler Name Meijer Distribution Inc
    Pharmaceutical Class Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA202319
    Listing Certified Through 2023-12-31

    Package

    NDC 41250-0117-03 (41250011703)

    NDC Package Code 41250-117-03
    Billing NDC 41250011703
    Package 3 BOTTLE in 1 CARTON (41250-117-03) / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE
    Marketing Start Date 2012-05-18
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL f9bf212f-7c8a-44f1-a71e-bd51756e9076 Details

    Revised: 5/2020